Analytical Data
-
Gene name
alp2
- Application
-
Alternative Names
(ALP2)(Autophagic serine protease alp2)(allergen Asp f 18)
-
Species
Neosartorya fumigata
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P87184
-
Expression Region
137-495aa
-
Molecular Weight
45.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the alp2 recombinant protein is rooted in the exploration of its biological significance and potential applications in various fields such as medicine and biotechnology. Alp2, a protein associated with the cellular processes in certain organisms, has drawn attention due to its role in cellular differentiation and stress response mechanisms. Research indicates that it may have implications in understanding disease pathways, particularly in conditions linked to abnormal cellular function. The production of alp2 as a recombinant protein allows for detailed investigations into its structure-function relationships, facilitating insights into its mechanism of action. Furthermore, recombinant alp2 can be utilized in therapeutic strategies, including vaccine development and targeted treatments, highlighting its potential in combating infectious diseases and improving health outcomes. The advancement in techniques for recombinant protein expression and purification has significantly accelerated research in this area, enabling scientists to characterize alp2 comprehensively and explore its interactions with other biomolecules. This burgeoning field of study not only promises to deepen our understanding of fundamental biological processes but also opens doors for innovative applications in drug development and protein engineering. As such, the investigation of alp2 recombinant protein is a critical step toward harnessing its potential for scientific and medical advancements.
